Filed: 8/14/2026ACC: 0001389933-26-000006
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 88 equity positions with a total reported market value of $524.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
88
Positions
$524.36M
Total AUM (reported)
44.05M
Total Shares
Allocation by class
COM$351.18M67.0%
COM NEW$70.21M13.4%
ETF$39.20M7.5%
SPONSORED ADS$34.64M6.6%
ORD SHS$12.93M2.5%
SHS$6.57M1.3%
SPON ADR$3.90M0.7%
Portfolio Concentration
Top 3$164.94M31.5%
4–10$129.80M24.8%
11–25$123.62M23.6%
Rest$106.00M20.2%
Top 3 weight
31.5%
Top 10 weight
56.2%
Voting Authority Distribution
Total shares with voting rights: 44.05M
Sole
Full voting authority
44.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole88
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings88
Rows:
REVOLUTION MEDICINES INC
SOLEShares562.63K
TypeSH
Market value$105.37M
20.09%
Sole
562.63K
Shared
0.00
None
0.00
SPDR S&P BIOTECH ETF
SOLEShares196.50K
TypeSH
Market value$31.10M
5.93%
Sole
196.50K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares2.01M
TypeSH
Market value$28.47M
5.43%
Sole
2.01M
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$23.53M
4.49%
Sole
13.68M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares318.38K
TypeSH
Market value$22.23M
4.24%
Sole
318.38K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares739.01K
TypeSH
Market value$19.01M
3.62%
Sole
739.01K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares497.24K
TypeSH
Market value$18.53M
3.53%
Sole
497.24K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares597.43K
TypeSH
Market value$16.72M
3.19%
Sole
597.43K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares250.77K
TypeSH
Market value$15.14M
2.89%
Sole
250.77K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares172K
TypeSH
Market value$14.65M
2.79%
Sole
172K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares441.83K
TypeSH
Market value$13.62M
2.60%
Sole
441.83K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares48.47K
TypeSH
Market value$12.93M
2.47%
Sole
48.47K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares57.77K
TypeSH
Market value$9.74M
1.86%
Sole
57.77K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares208.96K
TypeSH
Market value$9.65M
1.84%
Sole
208.96K
Shared
0.00
None
0.00
INSULET CORP
SOLEShares61.87K
TypeSH
Market value$9.42M
1.80%
Sole
61.87K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares226.82K
TypeSH
Market value$9.22M
1.76%
Sole
226.82K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares284.95K
TypeSH
Market value$8.46M
1.61%
Sole
284.95K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares42.59K
TypeSH
Market value$8.10M
1.54%
Sole
42.59K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares335.25K
TypeSH
Market value$7.33M
1.40%
Sole
335.25K
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
SOLEShares171.01K
TypeSH
Market value$6.13M
1.17%
Sole
171.01K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares2.01M
TypeSH
Market value$6.12M
1.17%
Sole
2.01M
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares2.40M
TypeSH
Market value$5.88M
1.12%
Sole
2.40M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares86.28K
TypeSH
Market value$5.81M
1.11%
Sole
86.28K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares149.52K
TypeSH
Market value$5.76M
1.10%
Sole
149.52K
Shared
0.00
None
0.00
INOGEN INC
SOLEShares845.18K
TypeSH
Market value$5.45M
1.04%
Sole
845.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 562.63K | SH | $105.37M 20.09% | 562.63K | 0.00 | 0.00 |
SPDR S&P BIOTECH ETFSOLE | ETF | 196.50K | SH | $31.10M 5.93% | 196.50K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 2.01M | SH | $28.47M 5.43% | 2.01M | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $23.53M 4.49% | 13.68M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 318.38K | SH | $22.23M 4.24% | 318.38K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 739.01K | SH | $19.01M 3.62% | 739.01K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 497.24K | SH | $18.53M 3.53% | 497.24K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 597.43K | SH | $16.72M 3.19% | 597.43K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 250.77K | SH | $15.14M 2.89% | 250.77K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 172K | SH | $14.65M 2.79% | 172K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 441.83K | SH | $13.62M 2.60% | 441.83K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | ORD SHS | 48.47K | SH | $12.93M 2.47% | 48.47K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 57.77K | SH | $9.74M 1.86% | 57.77K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 208.96K | SH | $9.65M 1.84% | 208.96K | 0.00 | 0.00 |
INSULET CORPSOLE | COM | 61.87K | SH | $9.42M 1.80% | 61.87K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 226.82K | SH | $9.22M 1.76% | 226.82K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 284.95K | SH | $8.46M 1.61% | 284.95K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 42.59K | SH | $8.10M 1.54% | 42.59K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 335.25K | SH | $7.33M 1.40% | 335.25K | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCSOLE | COM | 171.01K | SH | $6.13M 1.17% | 171.01K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 2.01M | SH | $6.12M 1.17% | 2.01M | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 2.40M | SH | $5.88M 1.12% | 2.40M | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 86.28K | SH | $5.81M 1.11% | 86.28K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 149.52K | SH | $5.76M 1.10% | 149.52K | 0.00 | 0.00 |
INOGEN INCSOLE | COM | 845.18K | SH | $5.45M 1.04% | 845.18K | 0.00 | 0.00 |
Page 1 of 4